These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7658914)

  • 1. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant human erythropoietin on anaemic W/Wv and Sl/Sld mice.
    Cynshi O; Satoh K; Higuchi M; Imai N; Kawaguchi T; Hirashima K
    Br J Haematol; 1990 Jul; 75(3):319-24. PubMed ID: 2386767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
    Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
    Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of erythropoietin in genetically anemic mice.
    Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
    Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
    Akahane K; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F
    Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible role of soluble erythropoietin receptors in renal anemia].
    Sakaguchi M; Maeda Y; Naiki Y; Hasegawa H; Kanamaru A
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):524-9. PubMed ID: 12476588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 3 can compensate for the deficiency in erythroid burst-forming cells in anemic mice of genotype W/Wv.
    Goldwasser E; Pech N; Ihle J
    Exp Hematol; 1990 Sep; 18(8):936-9. PubMed ID: 2387344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation.
    Millot S; Andrieu V; Letteron P; Lyoumi S; Hurtado-Nedelec M; Karim Z; Thibaudeau O; Bennada S; Charrier JL; Lasocki S; Beaumont C
    Blood; 2010 Dec; 116(26):6072-81. PubMed ID: 20844235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of bone marrow cellularity during erythropoietin treatment in myeloma.
    Ludwig H; Chott A; Fritz E; Krainer M
    Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients].
    Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of lethal c-KitW/W mice by erythropoietin.
    Waskow C; Terszowski G; Costa C; Gassmann M; Rodewald HR
    Blood; 2004 Sep; 104(6):1688-95. PubMed ID: 15178584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
    Slavova-Azmanova NS; Kucera N; Satiaputra J; Stone L; Magno A; Maxwell MJ; Quilici C; Erber W; Klinken SP; Hibbs ML; Ingley E
    Blood; 2013 Jul; 122(2):262-71. PubMed ID: 23692855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?
    Cruz DN; Perazella MA; Abu-Alfa AK; Mahnensmith RL
    Am J Kidney Dis; 1996 Oct; 28(4):535-40. PubMed ID: 8840943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and biological effects of recombinant human erythropoietin.
    Egrie JC; Strickland TW; Lane J; Aoki K; Cohen AM; Smalling R; Trail G; Lin FK; Browne JK; Hines DK
    Immunobiology; 1986 Sep; 172(3-5):213-24. PubMed ID: 3542810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.